Creegan & Nassoura Financial Group’s Medtronic MDT Stock Holding History

Creegan & Nassoura Financial Group’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$2.08M	Sell	21,682 -1,100	-5%	-$107K	1.35%	31
2025 Q3	$2.17M	Sell	22,782 -1,995	-8%	-$183K	1.4%	30
2025 Q2	$2.16M	Sell	24,777 -43	-0.2%	-$3.65K	1.41%	31
2025 Q1	$2.23M	Hold	24,820	–	–	1.49%	29
2024 Q4	$1.98M	Sell	24,820 -225	-0.9%	-$19.5K	1.33%	28
2024 Q3	$2.25M	Hold	25,045	–	–	1.42%	30
2024 Q2	$1.97M	Buy	25,045 +380	+2%	+$31.2K	1.35%	31
2024 Q1	$2.15M	Sell	24,665 -200	-0.8%	-$17.1K	1.44%	29
2023 Q4	$2.05M	Buy	24,865 +550	+2%	+$41.9K	1.49%	27
2023 Q3	$1.91M	Buy	24,315 +545	+2%	+$45.6K	1.48%	28
2023 Q2	$2.09M	Buy	23,770 +295	+1%	+$25.4K	1.55%	27
2023 Q1	$1.89M	Buy	23,475 +255	+1%	+$20.8K	1.45%	30
2022 Q4	$1.8M	Buy	23,220 +6,371	+38%	+$516K	1.41%	33
2022 Q3	$1.36M	Buy	+16,849	New	+$1.51M	1.18%	34

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Creegan & Nassoura Financial Group's MDT Position: Q4 2025 in Review

Creegan & Nassoura Financial Group reduced its Medtronic (MDT) stake by 4.8% in Q4 2025, selling an estimated $107K and leaving 21,682 shares worth $2.08M. The position accounts for 1.35% of the portfolio, ranked #31.

Creegan & Nassoura Financial Group first reported a position in MDT in Q3 2022 and has held it in 14 quarters since. The position peaked at $2.25M in Q3 2024. 2,304 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

Creegan & Nassoura Financial Group held 21,682 shares of Medtronic worth $2.08M as of Q4 2025.
Creegan & Nassoura Financial Group sold 1,100 Medtronic shares in Q4 2025, an estimated $107K.
Medtronic made up 1.35% of Creegan & Nassoura Financial Group's portfolio in Q4 2025, its #31 holding.
Creegan & Nassoura Financial Group first reported a position in Medtronic in Q3 2022 and has held it in 14 quarters since.
Creegan & Nassoura Financial Group's Medtronic position peaked at $2.25M in Q3 2024.
2,304 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Creegan & Nassoura Financial Group's 13F filing for Q4 2025, filed 17 Feb 2026.